By BioWorld

closed 7/3/2013 via Company Press Release

Thomson Reuters, acquired BioWorld

synopsis: BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals. BioWorld covers news on public companies and hard-to-find information on private companies.
buyer: Thomson Reuters (TRI:$5,906.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. It combines industry expertise with innovative technology to deliver critical information to leading decision makers. "
target parent: Thompson Media Group LLC
target: BioWorld
BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2013 via Company Press Release

Thomson Reuters, acquired BioWorld

synopsis: BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals. BioWorld covers news on public companies and hard-to-find information on private companies.
buyer: Thomson Reuters (TRI:$5,906.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. It combines industry expertise with innovative technology to deliver critical information to leading decision makers. "
target parent: Thompson Media Group LLC
target: BioWorld
BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2006 via Company Press Release

Cambridge Heathtech Institute, acquired Bio-IT World

synopsis: Cambridge Healthtech Institute of Newton today announced the acquisition of Bio-IT World, Inc.’s media and events properties. The flagship publication, Bio-IT World magazine, introduced in March 2002, has grown from a 10-times-per-year publication to include a range of online and event businesses.
buyer: Cambridge Heathtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress. "
target parent: International Data Group
target: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/23/2016 via Market Wire

Cambridge Healthtech Institute, acquired Neurotech Investing and Partnering Conferences

synopsis: Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute (CII), announces the acquisition of the Neurotech Investing and Partnering Conference and the European Neurotech Investing and Partnering Summit, two of the industry's premier business and investment conferences for commercial neuroscience.
buyer: Cambridge Healthtech Institute
Cambridge Healthtech Institute is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI includes conferences, reports, educational services, consulting, publications & eNewsletters, and professional services."
target: Neurotech Investing and Partnering Conferences
The Neurotech Investing and Partnering Conference is the premier partnering and investing conference for the neurotechnology industry, spanning pharmaceuticals, medical devices, software and diagnostics for thebrain and nervous system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via Market Wire

Bio-IT World, acquired OpenHelix, LLC

synopsis: OpenHelix, a provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web, will join the Cambridge Healthtech Institute as a division of Bio-IT World, a leading source of news and opinion on technology and strategic innovation in the life sciences.
buyer parent: Cambridge Healthtech Institute
buyer: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals. "
target: OpenHelix, LLC
OpenHelix, a Washington State company, was founded in 2003 to provide training on what was then a fledgling but quickly growing market of open access web based bioinformatics resources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2019 via PR Newswire

Crain Communications, Inc., acquired Genomeweb LLC

synopsis: Crain Communications Inc has acquired GenomeWeb, an online news organization serving the global community of scientists, technology professionals and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb was launched in 1997 and has a staff of 30 employees located in New York.
buyer: Crain Communications, Inc.
Crain Communications is a privately held media company that produces trusted and relevant news publications, lead generation, research and data products, digital platforms, custom publishing, and events with uncompromising integrity. "
target: Genomeweb LLC
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2020 via BNC Analysis

Comexposium SA, will acquire Europa Group

synopsis: France-based global events organiser Comexposium has acquired Europa Group, a leading healthcare and scientific congress organiser in Europe. Europa Group creates tailor-made congresses and events that allow professionals from around the world to meet, learn, and exchange ideas.
buyer: Comexposium SA
Comexposium is one of the world’s leading event organizers. Globally, it hosts more than 177 B2B and B2C events across many different sectors, including food, agriculture, retail, e-commerce, fashion, security, digital, construction, high-tech, optics and transport. "
target: Europa Group
Europa Group is a leading healthcare and scientific congress organiser in Europe. Europa Group creates tailor-made congresses and events that allow professionals from around the world to meet, learn, and exchange ideas. The group organises more than 200 professional events worldwide every year.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2012 via BusinessWire

LifeMap Sciences, Inc., acquired XenneX, Inc.

synopsis: BioTime, Inc. and its wholly owned subsidiary, LifeMap Sciences, announced that they have completed the acquisition of XenneX, Inc. through a merger of XenneX into LifeMap Sciences. XenneX provides biotechnology, pharmaceutical and other life sciences companies, services and tools to enhance their bio-medical research.
buyer parent: BioTime, Inc.
buyer: LifeMap Sciences, Inc.
LifeMap Sciences, Inc. is developing a discovery platform, including a web-based database, to aid researchers in the use of embryonic stem cells, progenitor cells, and induced pluripotent stem cells for the development of new products and technologies in the emerging field of regenerative medicine. "
target: XenneX, Inc.
XenneX, Inc. is a privately held company that is dedicated to providing biotechnology, pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/7/2016 via GlobeNewswire

Curetis N.V., will purchase GEAR Database from Siemens Technology Accelerator GmbH

synopsis: Curetis N.V., a developer of next-level molecular diagnostic solutions, announced the signing of an asset acquisition agreement with the Siemens Technology Accelerator GmbH, Siemen AG's venture capital arm, to acquire the sole commercial rights to the GEAR Genetic Antibiotic Resistance and Susceptibility platform and database.
buyer: Curetis N.V. (ENXTAM:CURE:$2.25)
Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious disease. "
seller parent: Siemens AG
seller: Siemens Technology Accelerator GmbH
The acquisition includes the The Genetic Antibiotic Resistance and Susceptibility platform and database. The GEAR database includes genomic data of mostly Gram negative bacteria causing pneumonia, bloodstream infections, urinary tract infections, and gastric and wound infections.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/8/2011 via PR Newswire

Elsevier B.V., acquired Ariadne Genomics, Inc.

synopsis: Elsevier, a world-leading provider of scientific, technical, and medical information products and services, announced the acquisition of the business assets of Ariadne Genomics, a provider of pathway analysis tools and semantic technologies for life science researchers. Ariadne will be integrated with Elsevier's Corporate Markets division.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals and close to 20,000 book titles. "
target: Ariadne Genomics, Inc.
Ariadne Genomics, a leader in research data products and knowledge enrichment-based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2006 via BusinessWire

BioWisdom, Ltd., purchased Bioinformatics Business from LION bioscience AG

synopsis: LION bioscience AG has successfully completed the sale of its bioinformatics business to BioWisdom Ltd, UK. The consideration will be up to EUR 4 million and the deal is due to be completed by April 4, 2006. As a result of this transaction, the company has achieved a major milestone in its restructuring plans, which commenced over a year ago.
buyer: BioWisdom, Ltd.
BioWisdom Ltd., headquartered in Cambridge UK, and established in September 2000, is a world leader in Ontology, a branch of science that seeks to enhance communication between people and improve access to information. "
seller: LION bioscience AG
At the heart of LION’s offering is SRS, the world’s leading integration software for biological data, which seamlessly integrates information from hundreds of publicly available databases with in-house research data.
price ($mm)
$5.36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2013 via Company Press Release

Thomson Reuters, acquired BioWorld

synopsis: BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals. BioWorld covers news on public companies and hard-to-find information on private companies.
buyer: Thomson Reuters (TRI:$5,906.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. It combines industry expertise with innovative technology to deliver critical information to leading decision makers. "
target parent: Thompson Media Group LLC
target: BioWorld
BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2006 via Company Press Release

Cambridge Heathtech Institute, acquired Bio-IT World

synopsis: Cambridge Healthtech Institute of Newton today announced the acquisition of Bio-IT World, Inc.’s media and events properties. The flagship publication, Bio-IT World magazine, introduced in March 2002, has grown from a 10-times-per-year publication to include a range of online and event businesses.
buyer: Cambridge Heathtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress. "
target parent: International Data Group
target: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/23/2016 via Market Wire

Cambridge Healthtech Institute, acquired Neurotech Investing and Partnering Conferences

synopsis: Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute (CII), announces the acquisition of the Neurotech Investing and Partnering Conference and the European Neurotech Investing and Partnering Summit, two of the industry's premier business and investment conferences for commercial neuroscience.
buyer: Cambridge Healthtech Institute
Cambridge Healthtech Institute is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI includes conferences, reports, educational services, consulting, publications & eNewsletters, and professional services."
target: Neurotech Investing and Partnering Conferences
The Neurotech Investing and Partnering Conference is the premier partnering and investing conference for the neurotechnology industry, spanning pharmaceuticals, medical devices, software and diagnostics for thebrain and nervous system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via Market Wire

Bio-IT World, acquired OpenHelix, LLC

synopsis: OpenHelix, a provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web, will join the Cambridge Healthtech Institute as a division of Bio-IT World, a leading source of news and opinion on technology and strategic innovation in the life sciences.
buyer parent: Cambridge Healthtech Institute
buyer: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals. "
target: OpenHelix, LLC
OpenHelix, a Washington State company, was founded in 2003 to provide training on what was then a fledgling but quickly growing market of open access web based bioinformatics resources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2019 via PR Newswire

Crain Communications, Inc., acquired Genomeweb LLC

synopsis: Crain Communications Inc has acquired GenomeWeb, an online news organization serving the global community of scientists, technology professionals and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb was launched in 1997 and has a staff of 30 employees located in New York.
buyer: Crain Communications, Inc.
Crain Communications is a privately held media company that produces trusted and relevant news publications, lead generation, research and data products, digital platforms, custom publishing, and events with uncompromising integrity. "
target: Genomeweb LLC
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2020 via BNC Analysis

Comexposium SA, will acquire Europa Group

synopsis: France-based global events organiser Comexposium has acquired Europa Group, a leading healthcare and scientific congress organiser in Europe. Europa Group creates tailor-made congresses and events that allow professionals from around the world to meet, learn, and exchange ideas.
buyer: Comexposium SA
Comexposium is one of the world’s leading event organizers. Globally, it hosts more than 177 B2B and B2C events across many different sectors, including food, agriculture, retail, e-commerce, fashion, security, digital, construction, high-tech, optics and transport. "
target: Europa Group
Europa Group is a leading healthcare and scientific congress organiser in Europe. Europa Group creates tailor-made congresses and events that allow professionals from around the world to meet, learn, and exchange ideas. The group organises more than 200 professional events worldwide every year.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2012 via BusinessWire

LifeMap Sciences, Inc., acquired XenneX, Inc.

synopsis: BioTime, Inc. and its wholly owned subsidiary, LifeMap Sciences, announced that they have completed the acquisition of XenneX, Inc. through a merger of XenneX into LifeMap Sciences. XenneX provides biotechnology, pharmaceutical and other life sciences companies, services and tools to enhance their bio-medical research.
buyer parent: BioTime, Inc.
buyer: LifeMap Sciences, Inc.
LifeMap Sciences, Inc. is developing a discovery platform, including a web-based database, to aid researchers in the use of embryonic stem cells, progenitor cells, and induced pluripotent stem cells for the development of new products and technologies in the emerging field of regenerative medicine. "
target: XenneX, Inc.
XenneX, Inc. is a privately held company that is dedicated to providing biotechnology, pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their bio-medical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/7/2016 via GlobeNewswire

Curetis N.V., will purchase GEAR Database from Siemens Technology Accelerator GmbH

synopsis: Curetis N.V., a developer of next-level molecular diagnostic solutions, announced the signing of an asset acquisition agreement with the Siemens Technology Accelerator GmbH, Siemen AG's venture capital arm, to acquire the sole commercial rights to the GEAR Genetic Antibiotic Resistance and Susceptibility platform and database.
buyer: Curetis N.V. (ENXTAM:CURE:$2.25)
Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious disease. "
seller parent: Siemens AG
seller: Siemens Technology Accelerator GmbH
The acquisition includes the The Genetic Antibiotic Resistance and Susceptibility platform and database. The GEAR database includes genomic data of mostly Gram negative bacteria causing pneumonia, bloodstream infections, urinary tract infections, and gastric and wound infections.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/8/2011 via PR Newswire

Elsevier B.V., acquired Ariadne Genomics, Inc.

synopsis: Elsevier, a world-leading provider of scientific, technical, and medical information products and services, announced the acquisition of the business assets of Ariadne Genomics, a provider of pathway analysis tools and semantic technologies for life science researchers. Ariadne will be integrated with Elsevier's Corporate Markets division.
buyer parent: Reed Elsevier
buyer: Elsevier B.V.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals and close to 20,000 book titles. "
target: Ariadne Genomics, Inc.
Ariadne Genomics, a leader in research data products and knowledge enrichment-based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2006 via BusinessWire

BioWisdom, Ltd., purchased Bioinformatics Business from LION bioscience AG

synopsis: LION bioscience AG has successfully completed the sale of its bioinformatics business to BioWisdom Ltd, UK. The consideration will be up to EUR 4 million and the deal is due to be completed by April 4, 2006. As a result of this transaction, the company has achieved a major milestone in its restructuring plans, which commenced over a year ago.
buyer: BioWisdom, Ltd.
BioWisdom Ltd., headquartered in Cambridge UK, and established in September 2000, is a world leader in Ontology, a branch of science that seeks to enhance communication between people and improve access to information. "
seller: LION bioscience AG
At the heart of LION’s offering is SRS, the world’s leading integration software for biological data, which seamlessly integrates information from hundreds of publicly available databases with in-house research data.
price ($mm)
$5.36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

By BioWorld


read more

BioWorld

read more

BioWorld

Bio-IT World

Neurotech Investing and Partnering Conferences

OpenHelix, LLC

Genomeweb LLC

Europa Group

XenneX, Inc.

Siemens Technology Accelerator GmbH

Ariadne Genomics, Inc.

LION bioscience AG

read more

BioWorld

Bio-IT World

Neurotech Investing and Partnering Conferences

OpenHelix, LLC

Genomeweb LLC

Europa Group

XenneX, Inc.

Siemens Technology Accelerator GmbH

Ariadne Genomics, Inc.

LION bioscience AG

Geography
Matching Companies